ORIC Pharmaceuticals Inc (ORIC)
9.12
+0.38
(+4.35%)
USD |
NASDAQ |
Nov 21, 16:00
9.16
+0.04
(+0.44%)
After-Hours: 20:00
ORIC Pharmaceuticals Total Assets (Quarterly): 302.07M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 302.07M |
June 30, 2024 | 328.91M |
March 31, 2024 | 350.79M |
December 31, 2023 | 252.01M |
September 30, 2023 | 274.34M |
June 30, 2023 | 291.82M |
March 31, 2023 | 226.65M |
December 31, 2022 | 247.18M |
September 30, 2022 | 238.00M |
June 30, 2022 | 259.68M |
Date | Value |
---|---|
March 31, 2022 | 275.06M |
December 31, 2021 | 298.64M |
September 30, 2021 | 314.18M |
June 30, 2021 | 268.23M |
March 31, 2021 | 283.96M |
December 31, 2020 | 299.00M |
September 30, 2020 | 191.66M |
June 30, 2020 | 201.52M |
March 31, 2020 | 85.06M |
December 31, 2019 | 94.09M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
85.06M
Minimum
Mar 2020
350.79M
Maximum
Mar 2024
254.14M
Average
271.28M
Median
Total Assets (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.877M |
Palatin Technologies Inc | 3.415M |
iBio Inc | 24.52M |
Theriva Biologics Inc | 40.11M |
Oragenics Inc | 5.204M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 28.08M |
Shareholders Equity (Quarterly) | 273.99M |